GoHealth Statistics
Total Valuation
GoHealth has a market cap or net worth of 5.84 million. The enterprise value is 583.16 million.
| Market Cap | 5.84M |
| Enterprise Value | 583.16M |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
GoHealth has 16.69 million shares outstanding. The number of shares has increased by 41.91% in one year.
| Current Share Class | 16.69M |
| Shares Outstanding | 16.69M |
| Shares Change (YoY) | +41.91% |
| Shares Change (QoQ) | +0.55% |
| Owned by Insiders (%) | 8.24% |
| Owned by Institutions (%) | 38.21% |
| Float | 10.15M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.04 |
| PB Ratio | -0.08 |
| P/TBV Ratio | 2.74 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 3.82 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.03
| Current Ratio | 2.03 |
| Quick Ratio | 1.96 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -6.39 |
| Interest Coverage | -1.91 |
Financial Efficiency
Return on equity (ROE) is -289.94% and return on invested capital (ROIC) is -32.12%.
| Return on Equity (ROE) | -289.94% |
| Return on Assets (ROA) | -10.59% |
| Return on Invested Capital (ROIC) | -32.12% |
| Return on Capital Employed (ROCE) | -24.75% |
| Weighted Average Cost of Capital (WACC) | 11.72% |
| Revenue Per Employee | 179,749 |
| Profits Per Employee | -345,742 |
| Employee Count | 850 |
| Asset Turnover | 0.13 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -3.73M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -93.59% in the last 52 weeks. The beta is 1.17, so GoHealth's price volatility has been higher than the market average.
| Beta (5Y) | 1.17 |
| 52-Week Price Change | -93.59% |
| 50-Day Moving Average | 0.83 |
| 200-Day Moving Average | 2.39 |
| Relative Strength Index (RSI) | 29.24 |
| Average Volume (20 Days) | 943,265 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 1.29 |
Income Statement
In the last 12 months, GoHealth had revenue of 152.79 million and -293.88 million in losses. Loss per share was -20.41.
| Revenue | 152.79M |
| Gross Profit | 87.62M |
| Operating Income | -194.91M |
| Pretax Income | -557.83M |
| Net Income | -293.88M |
| EBITDA | -147.98M |
| EBIT | -194.91M |
| Loss Per Share | -20.41 |
Balance Sheet
The company has 39.88 million in cash and 688.12 million in debt, with a net cash position of -648.24 million or -38.85 per share.
| Cash & Cash Equivalents | 39.88M |
| Total Debt | 688.12M |
| Net Cash | -648.24M |
| Net Cash Per Share | -38.85 |
| Equity (Book Value) | -68.79M |
| Book Value Per Share | 0.13 |
| Working Capital | 134.67M |
Cash Flow
In the last 12 months, operating cash flow was -102.56 million and capital expenditures -5.20 million, giving a free cash flow of -107.76 million.
| Operating Cash Flow | -102.56M |
| Capital Expenditures | -5.20M |
| Depreciation & Amortization | 46.94M |
| Net Borrowing | 138.00M |
| Free Cash Flow | -107.76M |
| FCF Per Share | -6.46 |
Margins
Gross margin is 57.34%, with operating and profit margins of -127.57% and -189.73%.
| Gross Margin | 57.34% |
| Operating Margin | -127.57% |
| Pretax Margin | -365.10% |
| Profit Margin | -189.73% |
| EBITDA Margin | -96.85% |
| EBIT Margin | -127.57% |
| FCF Margin | n/a |
Dividends & Yields
GoHealth does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -41.91% |
| Shareholder Yield | -41.91% |
| Earnings Yield | -5,032.00% |
| FCF Yield | -1,845.06% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Analyst Forecast
The average price target for GoHealth is 5.17, which is 1,377.14% higher than the current price. The consensus rating is "Buy".
| Price Target | 5.17 |
| Price Target Difference | 1,377.14% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (3Y) | 14.84% |
| EPS Growth Forecast (3Y) | n/a |
Stock Splits
The last stock split was on November 18, 2022. It was a reverse split with a ratio of 0.0666667.
| Last Split Date | Nov 18, 2022 |
| Split Type | Reverse |
| Split Ratio | 0.0666667 |
Scores
GoHealth has an Altman Z-Score of -1.42 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1.42 |
| Piotroski F-Score | 2 |